1-(4-Methylphenyl)ethanol
Common Name: |
1-(4-Methylphenyl)ethanol |
IUPAC Name: |
1-(4-methylphenyl)ethanol |
Molecular Formula: |
C9H12O |
SMILES: |
CC1=CC=C(C=C1)C(C)O |
Inchi: |
1S/C9H12O/c1-7-3-5-9(6-4-7)8(2)10/h3-6,8,10H,1-2H3 |
Inchi Key: |
JESIHYIJKKUWIS-UHFFFAOYSA-N |
Cas No: |
536-50-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
136.19 |
Mass (g/mol) |
136.089 |
Molar Refractivity |
42.34 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
134.00 @ 14.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.085 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
2.048 |
iLOGP |
2.14 |
XLOGP3 |
1.80 |
WLOGP |
1.72 |
MLOGP |
2.19 |
ESOL Log S |
-2.20 |
ESOL Solubility (mg/ml) |
0.866 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-1.84 |
Ali Solubility (mg/ml) |
1.95 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.61 |
Silicos-IT Solubility (mg/ml) |
0.33 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.85 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.76 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.484 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |